Soticlestat
TAK-935-3003
Phase 3 small_molecule terminated
Quick answer
Soticlestat for Dravet Syndrome (DS) is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Dravet Syndrome (DS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated